Published in Radiat Oncol on July 11, 2012
Comparing four volumetric modulated arc therapy beam arrangements for the treatment of early-stage prostate cancer. J Med Radiat Sci (2014) 0.80
Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc. Radiat Oncol (2016) 0.75
Dosimetric effects of sectional adjustments of collimator angles on volumetric modulated arc therapy for irregularly-shaped targets. PLoS One (2017) 0.75
A technique for the quantitative evaluation of dose distributions. Med Phys (1998) 7.49
Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys (2008) 6.43
IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys (2009) 4.47
Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys (2008) 3.65
Single-Arc IMRT? Phys Med Biol (2008) 3.30
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys (2002) 2.65
Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys (2005) 2.14
Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? Radiother Oncol (2009) 2.00
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys (2009) 1.97
Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol (2008) 1.91
RapidArc volumetric modulated therapy planning for prostate cancer patients. Acta Oncol (2009) 1.74
Development and evaluation of an efficient approach to volumetric arc therapy planning. Med Phys (2009) 1.65
Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys (2009) 1.31
Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys (2002) 1.23
Treatment planning for volumetric modulated arc therapy. Med Phys (2009) 1.23
Clinical applications of volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys (2010) 1.23
Evaluation of volumetric modulated arc therapy (VMAT) with Oncentra MasterPlan® for the treatment of head and neck cancer. Radiat Oncol (2010) 1.21
New developments in arc radiation therapy: a review. Cancer Treat Rev (2010) 1.19
Guidelines for primary radiotherapy of patients with prostate cancer. Radiother Oncol (2006) 1.15
Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives. Strahlenther Onkol (2007) 1.15
Comparison of direct machine parameter optimization versus fluence optimization with sequential sequencing in IMRT of hypopharyngeal carcinoma. Radiat Oncol (2007) 1.14
IMRT for breast. a planning study. Radiother Oncol (2005) 1.10
Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther Onkol (2005) 1.08
The number of beams in IMRT--theoretical investigations and implications for single-arc IMRT. Phys Med Biol (2010) 1.03
Initial dosimetric evaluation of SmartArc - a novel VMAT treatment planning module implemented in a multi-vendor delivery chain. J Appl Clin Med Phys (2010) 1.01
Letter to the Editor on 'Single-Arc IMRT?'. Phys Med Biol (2009) 0.99
Inverse planning--a comparative intersystem and interpatient constraint study. Strahlenther Onkol (2006) 0.98
Some considerations concerning volume-modulated arc therapy: a stepping stone towards a general theory. Phys Med Biol (2009) 0.98
Angular dose dependence of Matrixx TM and its calibration. J Appl Clin Med Phys (2010) 0.93
Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int J Radiat Oncol Biol Phys (2002) 0.91
Direct machine parameter optimization for intensity modulated radiation therapy (IMRT) of oropharyngeal cancer--a planning study. J Appl Clin Med Phys (2009) 0.90
A RapidArc planning strategy for prostate with simultaneous integrated boost. J Appl Clin Med Phys (2010) 0.89
IMRT-based optimization approaches for volumetric modulated single arc radiotherapy planning. Radiother Oncol (2010) 0.88
Commissioning of volumetric modulated arc therapy (VMAT) in a dual-vendor environment. Radiother Oncol (2011) 0.88
Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. Radiother Oncol (2004) 0.87
Hybrid plan verification for intensity-modulated radiation therapy (IMRT) using the 2D ionization chamber array I'mRT MatriXX--a feasibility study. Phys Med Biol (2009) 0.87
Image-guided, adaptive radiotherapy of prostate cancer: toward new standards of radiotherapy practice. Front Radiat Ther Oncol (2011) 0.87
IMRT of prostate cancer: a comparison of fluence optimization with sequential segmentation and direct step-and-shoot optimization. Strahlenther Onkol (2009) 0.85
Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment. Radiat Oncol (2010) 0.83
Does the option to rotate the Elekta Beam Modulator MLC during VMAT IMRT delivery confer advantage?--a study of 'parked gaps'. Phys Med Biol (2010) 0.83
Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2008) 0.81
Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate. Strahlenther Onkol (2006) 0.80
Fundamental properties of the delivery of volumetric modulated arc therapy (VMAT) to static patient anatomy. Med Phys (2010) 0.78
Analysis of RapidArc optimization strategies using objective function values and dose-volume histograms. J Appl Clin Med Phys (2009) 0.76
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol (2012) 2.97
Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer (2010) 1.66
Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.58
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol (2007) 1.43
Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys (2008) 1.27
Evaluation of volumetric modulated arc therapy (VMAT) with Oncentra MasterPlan® for the treatment of head and neck cancer. Radiat Oncol (2010) 1.21
IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach. Int J Radiat Oncol Biol Phys (2004) 1.19
Comparison of direct machine parameter optimization versus fluence optimization with sequential sequencing in IMRT of hypopharyngeal carcinoma. Radiat Oncol (2007) 1.14
Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther Onkol (2009) 1.08
Fistula-associated anal adenocarcinoma in Crohn's disease. Inflamm Bowel Dis (2010) 1.02
Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT. Strahlenther Onkol (2003) 0.96
Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials. Int J Radiat Oncol Biol Phys (2010) 0.95
Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol (2011) 0.92
Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases. BMC Cancer (2012) 0.91
A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors. Strahlenther Onkol (2008) 0.91
Direct machine parameter optimization for intensity modulated radiation therapy (IMRT) of oropharyngeal cancer--a planning study. J Appl Clin Med Phys (2009) 0.90
Commissioning of volumetric modulated arc therapy (VMAT) in a dual-vendor environment. Radiother Oncol (2011) 0.88
Improving dose homogeneity in large breasts by IMRT: efficacy and dosimetric accuracy of different techniques. Strahlenther Onkol (2008) 0.87
Hybrid plan verification for intensity-modulated radiation therapy (IMRT) using the 2D ionization chamber array I'mRT MatriXX--a feasibility study. Phys Med Biol (2009) 0.87
18F-FET-PET-based dose painting by numbers with protons. Strahlenther Onkol (2010) 0.86
The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty. Strahlenther Onkol (2005) 0.86
Frameless fractionated stereotactic radiation therapy of intracranial lesions: impact of cone beam CT based setup correction on dose distribution. Radiat Oncol (2013) 0.85
Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment? Radiat Oncol (2011) 0.85
On the performances of different IMRT Treatment Planning Systems for selected paediatric cases. Radiat Oncol (2007) 0.85
IMRT of prostate cancer: a comparison of fluence optimization with sequential segmentation and direct step-and-shoot optimization. Strahlenther Onkol (2009) 0.85
Stereotactic, single-dose irradiation of lung tumors: a comparison of absolute dose and dose distribution between pencil beam and Monte Carlo algorithms based on actual patient CT scans. Int J Radiat Oncol Biol Phys (2010) 0.84
[Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?]. Strahlenther Onkol (2009) 0.84
Quasi-IMAT technique and secondary cancer risk in prostate cancer. Strahlenther Onkol (2009) 0.84
Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment. Radiat Oncol (2010) 0.83
[Dosimetric impact of image-guided translational isocenter correction for 3-D conformal radiotherapy of the prostate]. Strahlenther Onkol (2007) 0.83
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature. Radiat Oncol (2006) 0.81
[Serial tomotherapy vs. MLC-IMRT (multileaf collimator intensity modulated radiotherapy) for simultaneous boost treatment large intracerebral lesions]. Z Med Phys (2009) 0.81
Frameless stereotactic radiosurgery of a solitary liver metastasis using active breathing control and stereotactic ultrasound. Strahlenther Onkol (2006) 0.80
Re-irradiation of spinal column metastases by IMRT: impact of setup errors on the dose distribution. Radiat Oncol (2013) 0.80
Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol (2003) 0.80
Influence of metallic dental implants and metal artefacts on dose calculation accuracy. Strahlenther Onkol (2014) 0.80
Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate. Strahlenther Onkol (2006) 0.80
Fatal course of tonsillar squamous cell carcinoma associated with Fanconi anaemia: a mini review. J Craniomaxillofac Surg (2011) 0.79
Changes of apoptosis, p53, and bcl-2 by irradiation in poorly differentiated thyroid carcinoma cell lines: a prognostic marker for the prospect of therapeutic success? Thyroid (2010) 0.79
Radiolabeled annexin V for imaging apoptosis in radiated human follicular thyroid carcinomas--is an individualized protocol necessary? Nucl Med Biol (2009) 0.79
Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy. Med Dosim (2012) 0.78
Image-guided in vivo dosimetry for quality assurance of IMRT treatment for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 0.77
Quality of life after treatment for prostate cancer: no difference between surgery and radiotherapy? J Clin Oncol (2003) 0.77
Monte Carlo simulations to replace film dosimetry in IMRT verification. Z Med Phys (2011) 0.76
In regard to Kapp et al.: experience with split-course external beam irradiation +/- chemotherapy and integrated (192)Ir high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. IJROBP 2001;49:997--1005. Int J Radiat Oncol Biol Phys (2002) 0.75
Increasing the number of patients in palliative research: ethical considerations. Support Cancer Ther (2006) 0.75
[Practical dosimetry and constancy check at introduction of intraoperative radiotherapy with Intrabeam (Zeiss)]. Z Med Phys (2009) 0.75
Fast rigid registration in radiation therapy. Stud Health Technol Inform (2006) 0.75
Management of small bowel interferences in primary radiotherapy of prostate cancer. Radiother Oncol (2005) 0.75
Stochastic triangulation for prostate positioning during radiotherapy using short CBCT arcs. Radiother Oncol (2013) 0.75
Clinical results of intracoronary brachytherapy (ICBT) for multiple in-stent restenosis. Strahlenther Onkol (2006) 0.75